These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9650545

  • 1. Effects of oral and intravenous terazosin and head-up tilt on blood pressure responses in patients with hypertension.
    Achari R, Hosmane B, Linnen P, Cavanaugh J, Baroldi P, Cohen A.
    J Clin Pharmacol; 1998 Jun; 38(6):545-53. PubMed ID: 9650545
    [Abstract] [Full Text] [Related]

  • 2. The relationship between terazosin dose and blood pressure response in hypertensive patients.
    Achari R, Hosmane B, Bonacci E, O'Dea R.
    J Clin Pharmacol; 2000 Oct; 40(10):1166-72. PubMed ID: 11028256
    [Abstract] [Full Text] [Related]

  • 3. Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive men.
    Kirby RS.
    Br J Urol; 1998 Sep; 82(3):373-9. PubMed ID: 9772873
    [Abstract] [Full Text] [Related]

  • 4. Alpha 2-agonist versus alpha 1-antagonist in mild-to-moderate hypertension: comparison of transdermal clonidine and terazosin monotherapies.
    Harris SI, Alvarez C.
    Am J Ther; 1997 Jan; 4(1):9-15. PubMed ID: 10423584
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
    Deger G.
    Am J Med; 1986 May 23; 80(5B):62-7. PubMed ID: 2872809
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of intravenous terazosin in hypertensive patients. A preliminary report.
    Cohen A.
    Am J Med; 1986 May 23; 80(5B):86-93. PubMed ID: 2872814
    [Abstract] [Full Text] [Related]

  • 7. Terazosin: an effective once-daily monotherapy for the treatment of hypertension.
    Dauer AD.
    Am J Med; 1986 May 23; 80(5B):29-34. PubMed ID: 2872804
    [Abstract] [Full Text] [Related]

  • 8. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B, Guy S, Humphreys JE.
    J Hum Hypertens; 1992 Jun 23; 6(3):221-5. PubMed ID: 1352828
    [Abstract] [Full Text] [Related]

  • 9. Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysis.
    Lowe FC.
    Urology; 1994 Jul 23; 44(1):46-51. PubMed ID: 7518981
    [Abstract] [Full Text] [Related]

  • 10. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG.
    Am J Med; 1986 May 23; 80(5B):55-61. PubMed ID: 2872808
    [Abstract] [Full Text] [Related]

  • 11. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.
    Pool JL.
    Am Heart J; 1991 Sep 23; 122(3 Pt 2):926-31. PubMed ID: 1678924
    [Abstract] [Full Text] [Related]

  • 12. A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing.
    de Mey C, Michel MC, McEwen J, Moreland T.
    Eur Urol; 1998 Sep 23; 33(5):481-8. PubMed ID: 9643668
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive dose-response relationships: studies with the selective alpha 1-blocking agent terazosin.
    Weber MA, Cheung DG, Laddu AR, Luther RR.
    Am Heart J; 1991 Sep 23; 122(3 Pt 2):905-10. PubMed ID: 1678921
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy and safety of terazosin alone and in combination with other antihypertensive agents.
    Cohen JD.
    Am Heart J; 1991 Sep 23; 122(3 Pt 2):919-25. PubMed ID: 1678923
    [Abstract] [Full Text] [Related]

  • 15. Effect of withdrawal of terazosin therapy in patients with hypertension.
    Ruoff G.
    Am J Med; 1986 May 23; 80(5B):35-41. PubMed ID: 2872805
    [Abstract] [Full Text] [Related]

  • 16. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R, Angeli-Greaves M, Carvajal AR, Guerrero Pajuelo J, Armas Padilla MC, Armas-Hernández MJ.
    Am J Hypertens; 1996 May 23; 9(5):437-44. PubMed ID: 8735174
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Djavan B, Marberger M.
    Eur Urol; 1999 May 23; 36(1):1-13. PubMed ID: 10364649
    [Abstract] [Full Text] [Related]

  • 20. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.
    Elhilali MM, Ramsey EW, Barkin J, Casey RW, Boake RC, Beland G, Fradet Y, Trachtenberg J, Orovan WL, Schick E, Klotz LH.
    Urology; 1996 Mar 23; 47(3):335-42. PubMed ID: 8633398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.